175 related articles for article (PubMed ID: 17535915)
21. The ARF-B23 connection: implications for growth control and cancer treatment.
Zhang Y
Cell Cycle; 2004 Mar; 3(3):259-62. PubMed ID: 14726681
[TBL] [Abstract][Full Text] [Related]
22. The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.
Okuwaki M; Tsujimoto M; Nagata K
Mol Biol Cell; 2002 Jun; 13(6):2016-30. PubMed ID: 12058066
[TBL] [Abstract][Full Text] [Related]
23. SMT3IP1, a nucleolar SUMO-specific protease, deconjugates SUMO-2 from nucleolar and cytoplasmic nucleophosmin.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):382-7. PubMed ID: 18639523
[TBL] [Abstract][Full Text] [Related]
24. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
Yeh CW; Huang SS; Lee RP; Yung BY
Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
[TBL] [Abstract][Full Text] [Related]
25. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
[TBL] [Abstract][Full Text] [Related]
26. In silico studies of potential phosphoresidues in the human nucleophosmin/B23: its kinases and related biological processes.
Ramos-Echazábal G; Chinea G; García-Fernández R; Pons T
J Cell Biochem; 2012 Jul; 113(7):2364-74. PubMed ID: 22573554
[TBL] [Abstract][Full Text] [Related]
27. TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification.
Neo SH; Itahana Y; Alagu J; Kitagawa M; Guo AK; Lee SH; Tang K; Itahana K
Mol Cell Biol; 2015 Aug; 35(16):2851-63. PubMed ID: 26055329
[TBL] [Abstract][Full Text] [Related]
28. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
[TBL] [Abstract][Full Text] [Related]
29. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.
Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT
J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315
[TBL] [Abstract][Full Text] [Related]
30. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
Weng CH; Yung BY; Weng JJ; Wu MH
J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
[TBL] [Abstract][Full Text] [Related]
31. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
32. Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity.
Murano K; Okuwaki M; Hisaoka M; Nagata K
Mol Cell Biol; 2008 May; 28(10):3114-26. PubMed ID: 18332108
[TBL] [Abstract][Full Text] [Related]
33. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
34. Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23.
Negi SS; Olson MO
J Cell Sci; 2006 Sep; 119(Pt 17):3676-85. PubMed ID: 16912078
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23.
Chou YH; Yung BY
Biochem Biophys Res Commun; 1995 Dec; 217(1):313-25. PubMed ID: 8526928
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the proliferative activity of a cell using new monoclonal antibodies to nucleolar protein B23/nucleophosmin].
Bulycheva TI; Dergunova NN; Artemenko EG; Dudnik OA; Shpakova AP; Malashenko OS; Zatsepina OV
Tsitologiia; 2000; 42(10):944-54. PubMed ID: 11200134
[TBL] [Abstract][Full Text] [Related]
37. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein.
Okuwaki M
J Biochem; 2008 Apr; 143(4):441-8. PubMed ID: 18024471
[TBL] [Abstract][Full Text] [Related]
38. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA.
Kawagishi H; Nakamura H; Maruyama M; Mizutani S; Sugimoto K; Takagi M; Sugimoto M
Cancer Res; 2010 Jun; 70(11):4749-58. PubMed ID: 20501856
[TBL] [Abstract][Full Text] [Related]
39. Nucleophosmin/B23 regulates PCNA promoter through YY1.
Weng JJ; Yung BY
Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
[TBL] [Abstract][Full Text] [Related]
40. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
Liu WH; Yung BY
Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
